iBio
IBIO
#9944
Rank
NZ$0.13 B
Marketcap
NZ$2.15
Share price
-6.62%
Change (1 day)
56.59%
Change (1 year)

Earnings for iBio (IBIO)

Earnings in 2026 (TTM): -NZ$47.06 Million

According to iBio's latest financial reports the company's current earnings are NZ$0.3 Million. In 2025 the company made an earning of -NZ$41.54 Million a decrease over its 2024 earnings that were of -NZ$23.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for iBio from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$47.06 Million13.3%
2025 -NZ$41.54 Million75.34%
2024 -NZ$23.69 Million-32.2%
2023 -NZ$34.94 Million-50.39%
2022 -NZ$70.42 Million122.23%
2021 -NZ$31.69 Million-12.52%
2020 -NZ$36.23 Million45%
2019 -NZ$24.98 Million-3.71%
2018 -NZ$25.95 Million5.52%
2017 -NZ$24.59 Million18.82%
2016 -NZ$20.7 Million60.34%
2015 -NZ$12.91 Million38.31%
2014 -NZ$9.34 Million25.01%
2013 -NZ$7.47 Million
2010 -NZ$20.69 Million360.89%
2009 -NZ$4.49 Million5.77%
2008 -NZ$4.25 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$43.92 B-94,696.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
-NZ$62.89 Million 35.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-NZ$0.26 Billion 454.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$99.93 M-315.20%๐Ÿ‡บ๐Ÿ‡ธ USA